Shopping Cart
- Remove All
- Your shopping cart is currently empty
STL1267 is a REV-ERB agonist that can cross the blood-brain barrier and inhibits BMAL1 gene expression. It can be used to study chronic diseases and inflammatory pain.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $56 | In Stock | |
5 mg | $89 | In Stock | |
10 mg | $139 | In Stock | |
25 mg | $289 | In Stock | |
50 mg | $479 | In Stock | |
100 mg | $762 | In Stock | |
1 mL x 10 mM (in DMSO) | $98 | In Stock |
Description | STL1267 is a REV-ERB agonist that can cross the blood-brain barrier and inhibits BMAL1 gene expression. It can be used to study chronic diseases and inflammatory pain. |
Targets&IC50 | REV-ERBα:0.16 µM (Ki) |
In vitro | STL1267 is an agonist of REV-ERB with a Ki value of 0.16 µM for Rev-erbα. The EC50 collected by STL1267 for NCoR ID1 is 0.13μM. [1] |
In vivo | Intraperitoneal injection of STL1267 (50 mg/kg) into C57Bl / 6 J mice showed that STL1267 successfully crossed the blood-brain barrier with a plasma half-life of ~1.6 hours. [1] |
Alias | STL 1267 |
Molecular Weight | 322.75 |
Formula | C17H11ClN4O |
Cas No. | 1429024-58-7 |
Smiles | ClC1=NN=C2C=CC(=NN12)OC=3C=CC=CC3C=4C=CC=CC4 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 20 mg/mL (61.97 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.